DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paclitaxel (Paclitaxel) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (123)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 123   Next >>

Possible Paclitaxel side effects in 54 year old female

Reported by a physician from United States on 2012-08-21

Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Pancytopenia, Platelet Count Decreased, Device Related Infection, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 mg/kg, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Carboplatin
    Dosage: 6 df, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Paclitaxel
    Dosage: 80 mg/m2, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Pegfilgrastim
    Dosage: 480 mug, unk
    Indication: Chemotherapy
    Start date: 2011-12-22

Other drugs received by patient: Tylenol (Caplet); Emend; Levaquin; Decadron; Zofran / 00955302 /; Aloxi; Compazine



Possible Paclitaxel side effects in 23 year old female

Reported by a physician from United States on 2012-08-14

Patient: 23 year old female, weighing 43.7 kg (96.1 pounds)

Reactions: Nephrolithiasis, Febrile Neutropenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 582 mg, cyclic, every 3 weeks
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-30
    End date: 2011-12-30

Carboplatin
    Dosage: 305 mg, once
    Start date: 2012-01-25
    End date: 2012-01-25

Crizotinib
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-07-26
    End date: 2011-12-29

Paclitaxel
    Dosage: 195 mg, once
    Start date: 2012-01-25
    End date: 2012-01-25

Paclitaxel
    Dosage: 280 mg, cyclic, every 3 weeks
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-30
    End date: 2011-12-30

Other drugs received by patient: Dexamethasone; Zofran; Lovenox; Bevacizumab; Xanax; Amitriptyline; Keppra; Bevacizumab; Ranitidine; Prochlorperazine; Lortab



Possible Paclitaxel side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-10

Patient: 71 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 98 mg, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-01-12

Paclitaxel
    Dosage: 343 mg, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-01-12

Other drugs received by patient: Prednisone TAB; Symbicort; Spiriva



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09

Patient: female

Reactions: Vomiting, Febrile Neutropenia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cisplatin
    Dosage: on day 1
    Indication: Endometrial Cancer

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Endometrial Cancer

Paclitaxel
    Dosage: on day 2
    Indication: Endometrial Cancer

Other drugs received by patient: Growth Hormone



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-08-03

Patient: female, weighing 43.7 kg (96.1 pounds)

Reactions: Nephrolithiasis, Febrile Neutropenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 305 mg, once
    Start date: 2012-01-25
    End date: 2012-01-25

Carboplatin
    Dosage: 582 mg, cyclic, every 3 weeks
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-30
    End date: 2011-12-30

Crizotinib
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-07-26
    End date: 2011-12-29

Paclitaxel
    Dosage: 280 mg, cyclic, every 3 weeks
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-30
    End date: 2011-12-30

Paclitaxel
    Dosage: 195 mg, once
    Start date: 2012-01-25
    End date: 2012-01-25

Other drugs received by patient: Bevacizumab; Dexamethasone; Zofran; Keppra; Bevacizumab; Prochlorperazine; Lovenox; Xanax; Amitriptyline; Ranitidine; Lortab



Possible Paclitaxel side effects in female

Reported by a physician from Ireland on 2012-08-02

Patient: female, weighing 94.9 kg (208.8 pounds)

Reactions: Febrile Neutropenia, Catheter Site Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2010-12-21
    End date: 2011-01-05

Afinitor
    Dosage: 10 mg daily
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-11-30
    End date: 2010-12-11

Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-01-27

Comparator Trastuzumab
    Dosage: 380 mg, unk
    Indication: Breast Cancer Metastatic
    Start date: 2010-11-30

Comparator Trastuzumab
    Dosage: no treatment received
    Start date: 2010-12-15
    End date: 2010-12-20

Comparator Trastuzumab
    Dosage: unk
    Start date: 2010-12-21

Comparator Trastuzumab
    Dosage: 190 mg, unk
    End date: 2010-12-07

Paclitaxel
    Dosage: no treatment received
    Start date: 2010-12-15
    End date: 2010-12-19

Paclitaxel
    Dosage: 60 mg, unk
    Start date: 2010-12-20

Paclitaxel
    Dosage: 80 mg/m2 day 1,8,5 of 28 day cycle
    Indication: Breast Cancer Metastatic
    End date: 2010-12-14

Other drugs received by patient: Naproxen; Amitriptline Hydrochloride TAB; Crestor; Atecor; Fluconazole



Possible Paclitaxel side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-30

Patient: male, weighing 83.3 kg (183.3 pounds)

Reactions: Febrile Neutropenia, Oropharyngeal Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Start date: 2012-07-12

Paclitaxel
    Start date: 2012-07-12



Possible Paclitaxel side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20

Patient: 42 year old female

Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Dexamethasone
    Dosage: 12mg
    Indication: Premedication

Dithiaden
    Dosage: 2mg
    Indication: Premedication

Docetaxel
    Dosage: for 4 cycles
    Indication: Breast Cancer

Doxorubicin HCL
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Ondansetron
    Dosage: 8mg
    Indication: Antiemetic Supportive Care

Paclitaxel
    Dosage: over 1h on d1; part of act protocol; scheduled for 12w
    Indication: Breast Cancer

Ranitidine
    Dosage: 150mg
    Indication: Premedication



Possible Paclitaxel side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20

Patient: 42 year old female

Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Dexamethasone
    Dosage: 12mg
    Indication: Premedication

Dithiaden
    Dosage: 2mg
    Indication: Premedication

Docetaxel
    Dosage: for 4 cycles
    Indication: Breast Cancer

Doxorubicin HCL
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Ondansetron
    Dosage: 8mg
    Indication: Antiemetic Supportive Care

Paclitaxel
    Dosage: over 1h on d1; part of act protocol; scheduled for 12w
    Indication: Breast Cancer

Ranitidine
    Dosage: 150mg
    Indication: Premedication



Possible Paclitaxel side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20

Patient: 42 year old female

Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Dexamethasone
    Dosage: 12mg
    Indication: Premedication

Dithiaden
    Dosage: 2mg
    Indication: Premedication

Docetaxel
    Dosage: for 4 cycles
    Indication: Breast Cancer

Doxorubicin HCL
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Ondansetron
    Dosage: 8mg
    Indication: Antiemetic Supportive Care

Paclitaxel
    Dosage: over 1h on d1; part of act protocol; scheduled for 12w
    Indication: Breast Cancer

Ranitidine
    Dosage: 150mg
    Indication: Premedication



Possible Paclitaxel side effects in 73 year old male

Reported by a consumer/non-health professional from United States on 2012-07-20

Patient: 73 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Febrile Neutropenia, Pulmonary Embolism, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Furosemide; Lansoprazole; Gasmotin; Maglax



Possible Paclitaxel side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-19

Patient:

Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite

Drug(s) suspected as cause:
Gemcitabine Hydrochloride
    Dosage: on days 1 and 8 every 21 days
    Indication: Breast Cancer

Herceptin
    Dosage: within 2 weeks after curative surgery until 52 weeks of therapy was completed

Herceptin
    Dosage: over 90 min on day 1
    Indication: Breast Cancer

Herceptin
    Dosage: over 30 min weekly

Paclitaxel
    Dosage: over 1 h on days 1 and 8 every 21 days
    Indication: Breast Cancer



Possible Paclitaxel side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-19

Patient: 42 year old female

Reactions: Febrile Neutropenia, Suicidal Ideation, Dysphemia, Anxiety, Hallucinations, Mixed, Transient Psychosis, Disturbance in Attention, Somatoform Disorder, Hallucination

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bisulepin
    Dosage: 2 mg
    Indication: Premedication

Dexamethasone
    Dosage: 12 mg
    Indication: Premedication

Ondansetron
    Dosage: 8 mg
    Indication: Premedication

Paclitaxel
    Dosage: 80 mg/m2, per week
    Indication: Breast Cancer

Ranitidine
    Dosage: 150 mg
    Indication: Premedication

Other drugs received by patient: Cyclophosphamide; Doxorubicin HCL



Possible Paclitaxel side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-18

Patient:

Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia

Drug(s) suspected as cause:
Gemcitabine Hydrochloride
    Indication: Breast Cancer

Gemcitabine Hydrochloride
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment

Herceptin
    Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
    Indication: Breast Cancer

Herceptin
    Dosage: after curative surgery until 52 weeks of therapy was completed.

Paclitaxel
    Indication: Breast Cancer

Paclitaxel
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 43.7 kg (96.1 pounds)

Reactions: Nephrolithiasis, Febrile Neutropenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 582 mg, cyclic, every 3 weeks
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-30
    End date: 2011-12-30

Carboplatin
    Dosage: 305 mg, once
    Start date: 2012-01-25
    End date: 2012-01-25

Crizotinib
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-07-27
    End date: 2011-12-29

Paclitaxel
    Dosage: 280 mg, cyclic, every 3 weeks
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-30
    End date: 2011-12-30

Paclitaxel
    Dosage: 195 mg, once
    Start date: 2012-01-25
    End date: 2012-01-25

Other drugs received by patient: Bevacizumab; Lovenox; Bevacizumab; Lortab; Prochlorperazine; Dexamethasone; Xanax; Amitriptyline; Zofran; Keppra; Ranitidine



Possible Paclitaxel side effects in 70 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 70 year old male, weighing 64.8 kg (142.6 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 465 mg once iv
    Start date: 2012-01-30
    End date: 2012-01-30

Paclitaxel
    Dosage: 372 mg once iv
    Indication: Oesophageal Squamous Cell Carcinoma
    Start date: 2012-01-30
    End date: 2012-01-30



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-11

Patient: female, weighing 48.5 kg (106.7 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: unk mg, qd
    Indication: Gastric Cancer
    Start date: 2012-05-31
    End date: 2012-06-21

Everolimus
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-05-31
    End date: 2012-07-05

Paclitaxel
    Dosage: 175 mg/m2, qw3
    Indication: Gastric Cancer
    Start date: 2012-05-31
    End date: 2012-06-21



Possible Paclitaxel side effects in 74 year old female

Reported by a physician from Japan on 2012-06-29

Patient: 74 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Blood Bilirubin Increased, General Physical Condition Abnormal, Urinary Tract Infection, Nail Avulsion, Febrile Neutropenia, Pancytopenia, Pyrexia, Rash, Haematemesis, Hepatic Encephalopathy, Oedema Peripheral, Duodenal Ulcer Haemorrhage, Stevens-Johnson Syndrome, Cardiac Failure Congestive, Hepatitis Fulminant

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Start date: 2010-04-27
    End date: 2010-04-27

Paclitaxel
    Start date: 2010-05-04
    End date: 2010-05-04

Paclitaxel
    Indication: Breast Cancer Stage II
    Start date: 2010-04-20
    End date: 2010-04-20

Taxotere
    Dosage: three [**] one [yasu]; cycles 1-11
    Indication: Breast Cancer Stage II
    Start date: 2010-06-10
    End date: 2010-09-08

Trastuzumab
    Dosage: dosage unknown and three [**] one [yasu]
    Indication: Breast Cancer Stage II
    Start date: 2010-04-20
    End date: 2010-05-11

Trastuzumab
    Start date: 2010-05-27

Other drugs received by patient: Zantac; Allegra; Allegra; Candesartan Cilexetil



Possible Paclitaxel side effects in 48 year old female

Reported by a physician from United States on 2012-06-28

Patient: 48 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Anaemia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2010-02-09

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2010-02-09

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2010-02-09

Paclitaxel
    Dosage: 80 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2010-02-09

Pegfilgrastim
    Dosage: 5 mug/kg, unk
    Indication: Breast Cancer
    Start date: 2010-02-09



Possible Paclitaxel side effects in 54 year old female

Reported by a physician from United States on 2012-06-26

Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Pancytopenia, Febrile Neutropenia, Device Related Infection, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 mg/kg, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Carboplatin
    Dosage: 6 df, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Paclitaxel
    Dosage: 80 mg/m2, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Pegfilgrastim
    Dosage: 480 mug, unk
    Indication: Chemotherapy
    Start date: 2011-12-22

Other drugs received by patient: Aloxi; Compazine; Decadron; Emend; Zofran; Tylenol (Caplet); Levaquin



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-06-18

Patient: female, weighing 59.0 kg (129.8 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer
    Start date: 2012-03-21

Doxorubicin HCL
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-03-21

Lapatinib
    Dosage: 500mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-21

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-03-21

Trastuzumab
    Dosage: 8mgk every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-03-21



Possible Paclitaxel side effects in 37 year old female

Reported by a physician from United States on 2012-06-07

Patient: 37 year old female, weighing 56.8 kg (125.0 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Febrile Neutropenia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 15 mg/kg, q3wk
    Indication: Breast Cancer
    Start date: 2008-09-30

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2008-09-30

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2008-09-30

Paclitaxel
    Dosage: 80 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2008-09-30

Paclitaxel
    Dosage: 6 mg, unk

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: Breast Cancer
    Start date: 2008-09-30



Possible Paclitaxel side effects in 54 year old female

Reported by a physician from United States on 2012-06-05

Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: White Blood Cell Count Decreased, Chills, Anaemia, Febrile Neutropenia, Headache, Hypokalaemia, Hypomagnesaemia, Platelet Count Decreased, Neutrophil Count Decreased, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 mg/kg, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Carboplatin
    Dosage: 6 df, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Cyclosporine
    Dosage: 1056 mg, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Doxorubicin HCL
    Dosage: 105 mg, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Paclitaxel
    Dosage: 80 mg/m2, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Pegfilgrastim
    Dosage: 480 mug, unk
    Indication: Chemotherapy
    Start date: 2011-12-22

Other drugs received by patient: Levaquin; Aloxi; Tylenol (Caplet); Compazine; Decadron; Emend; Zofran



Possible Paclitaxel side effects in male

Reported by a physician from Germany on 2012-06-04

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Stomatitis, Febrile Neutropenia, General Physical Health Deterioration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: non-Small Cell Lung Cancer

Avastin
    Dosage: reduced to 70%

Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-09

Paclitaxel
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-09



Possible Paclitaxel side effects in 40 year old female

Reported by a individual with unspecified qualification from United States on 2012-05-31

Patient: 40 year old female, weighing 63.3 kg (139.3 pounds)

Reactions: White Blood Cell Count Decreased, Febrile Neutropenia, Neutrophil Count Decreased, Lymphocyte Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: total dose 914 mg, last administered date 09 november 2011
    Indication: Cervix Carcinoma
    Start date: 2011-07-28

Paclitaxel
    Dosage: total dose 285 mg, last administered date 09 november 2011
    Indication: Cervix Carcinoma
    Start date: 2011-07-28

Topotecan Hydrochloride
    Dosage: total dose 3.6 mg, last administered date 11 november 2011
    Indication: Cervix Carcinoma
    Start date: 2011-07-28



Possible Paclitaxel side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-30

Patient:

Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite

Drug(s) suspected as cause:
Gemcitabine Hydrochloride
    Indication: Breast Cancer

Gemcitabine Hydrochloride
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment

Herceptin
    Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
    Indication: Breast Cancer

Herceptin
    Dosage: after curative surgery until 52 weeks of therapy was completed.

Paclitaxel
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment

Paclitaxel
    Indication: Breast Cancer



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: female

Reactions: Thrombosis, Agitation, Headache, Peripheral Sensory Neuropathy, Malaise, Granulocytopenia, Stomatitis, Hyperglycaemia, Anaemia, Intestinal Obstruction, Neutropenia, Bone Pain, Pain, Gastrointestinal Inflammation, Constipation, Hypokalaemia, Fatigue, Depression, Thrombocytopenia, Decreased Appetite, Lethargy, Pharyngitis, Vomiting, Dyspnoea, Nausea, Lymphopenia, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Hyponatraemia, Anxiety, Syncope, Embolism, Diarrhoea, Leukopenia, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Administration route: Oral

Cyclophosphamide
    Indication: Breast Cancer

Doxorubicin HCL
    Dosage: 60 mg/m2 for standard arm and 24 mg/m2 for continuous arm
    Indication: Breast Cancer

Granulocyte Colony Stimulating Factor
    Indication: Palliative Care

Paclitaxel
    Indication: Breast Cancer



Possible Paclitaxel side effects in 67 year old male

Reported by a physician from Greece on 2012-05-28

Patient: 67 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Diarrhoea, Chills, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-15

Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-15

Paclitaxel
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-15



Possible Paclitaxel side effects in

Reported by a individual with unspecified qualification from United States on 2012-05-28

Patient:

Reactions: Pain, Mental Status Changes, Pulmonary Embolism, Constipation, Neuropathy Peripheral, Fatigue, Dyspepsia, Oral Candidiasis, Oedema, Decreased Appetite, Hypovolaemia, Blood Alkaline Phosphatase Increased, Vomiting, Dysphagia, Nausea, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Brachial Plexopathy, Anxiety, Mucosal Inflammation, Insomnia, Aspartate Aminotransferase Increased, Dehydration, Neutropenia

Drug(s) suspected as cause:
Paclitaxel
    Dosage: on days 1-8
    Indication: Breast Cancer Metastatic

Xeloda
    Dosage: on days 1-15
    Administration route: Oral
    Indication: Breast Cancer Metastatic



Possible Paclitaxel side effects in 33 year old female

Reported by a physician from United States on 2012-05-27

Patient: 33 year old female, weighing 80.0 kg (176.0 pounds)

Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 mg/kg, unk
    Indication: Breast Cancer
    Start date: 2011-11-08

Carboplatin
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2011-11-08

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-08

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-08

Paclitaxel
    Dosage: 80 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-08

Pegfilgrastim
    Dosage: 24 mg, unk
    Indication: Chemotherapy
    Start date: 2012-03-21

Other drugs received by patient: Prochlorperazine; Ondansetron; Ibuprofen; Imodium



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017